Health Condition 1: - Health Condition 2: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Intervention1: ADMINISTERATION OF 4MG DEXAMETHASONE BEFORE INDUCTION: 65 PATIENTS WILL RECEIVE 4MG BOLUS DOSE OF DEXAMETHASONE AT THE TIME OF INDUCTION
Control Intervention1: SPLIT DOSE OF DEXAMETHASO
Sponsors
Dr Ananta Srilalita Bulusu
Eligibility
Inclusion criteria
Inclusion criteria: ASA CLASS 1 AND 2
Exclusion criteria
Exclusion criteria: 1.PATIENTS WHO REFUSE TO GIVE CONSENT 2.PATIENTS WHO HAVE HISTORY OF ALLERGY TO DEXAMETHASONE 3.PREGNANT PATIENTS 4.PATIENTS WITH DIABETES MELLITUS 5.RHEUMATOID IMMUNE SYSTEM DISEASES 6.LIVER AND KIDNEY FAILURE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO COMPARE THE EFFECTS OF SPLIT DOSE OF DEXAMETHASONE GIVEN PREOPERATIVELY AND POSTOPERATIVELY VERSUS SINGLE DOSE OF DEXAMETHASONE GIVEN PREOPERATIVELY ON POSTOPERATIVE NAUSEA AND VOMITING IN PATIENTS POSTED FOR LAPAROSCOPIC GYNAECOLOGIACAL SURGERIES LASTING 2-3 HOURSTimepoint: TO ASSESS POSTOPERATIVE NAUSEA VOMITING AT 0, 6, 12, 18, 24, 48, 72 HOURS | — |
Secondary
| Measure | Time frame |
|---|---|
| effect of dexamethasone on blood sugar levelsTimepoint: 24 hours after the surgery | — |
Countries
India
Contacts
Public ContactAnanta Srilalita Bulusu
Karnataka medical college and research institute
Outcome results
None listed